reference/5033297

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5033297

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	4654
issn	0732-183X 1527-7755
issueIdentifier	24
pageRange	4649-4654
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	4649
bibliographicCitation	Klasa RJ, Meyer RM, Shustik C, Sawka CA, Smith A, Guévin R, Maksymiuk A, Rubinger M, Samosh M, Laplante S, Grenier JF. Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen. J Clin Oncol. 2002 Dec 15;20(24):4649–54. doi: 10.1200/jco.2002.11.068. PMID: 12488409.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_956e9cb4f82e79ebba04c25faff86fcf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_838007e9c424028321081ab2a34cb82f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2349ef4df2a5b0779f568845a938445 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8d77e4266c5bf1795ad5056accdc30d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e90ac4f93a775c502572fc22e83116d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e18d4c8ffeef0e8b8d23c9b8b188fd09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb52cfba446fb0f8aaba806df193128e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0320033d7f8a18b1482b558c8d5769ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bb75cd4a2617a610a9ba196aed874f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7d13ffd94a52646ce1627f8dfea9234 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_630ac62dce2cd7f7089c429ca34d97b1
date	2002-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12488409 https://doi.org/10.1200/jco.2002.11.068
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Randomized Phase III Study of Fludarabine Phosphate Versus Cyclophosphamide, Vincristine, and Prednisone in Patients With Recurrent Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With an Alkylating Agent or Alkylator-Containing Regimen
discusses	http://id.nlm.nih.gov/mesh/M0082555 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0022659 http://id.nlm.nih.gov/mesh/M0022676
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014740Q000627 http://id.nlm.nih.gov/mesh/D003520Q000627 http://id.nlm.nih.gov/mesh/D014750Q000627 http://id.nlm.nih.gov/mesh/D014740Q000031 http://id.nlm.nih.gov/mesh/D008228Q000188 http://id.nlm.nih.gov/mesh/D011241Q000627 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D003520Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D014740Q000009 http://id.nlm.nih.gov/mesh/D014740Q000008 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D011241Q000009 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D014750Q000008 http://id.nlm.nih.gov/mesh/D014750Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6847 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8854 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30751 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657237

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127960150 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814614

Total number of triples: 84.